NCT04089150 2021-10-22
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
Clinical Trials
13 trialsNCT03703063 2021-01-27
Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer
Benaroya Research Institute
Phase 1 Unknown
NCT01821729 2020-09-25
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT03607643 2018-07-31
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
Phase 1/2 Unknown
NCT03167112 2017-08-29
Folfirinox
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Unknown
NCT02506842 2016-08-11
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Fudan University
Phase 3 Unknown
NCT01586611 2014-10-02
Panc001
AHS Cancer Control Alberta
Phase 3 Unknown
NCT01074996 2014-01-16
APC-S1
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2 Unknown
NCT01867892 2013-06-04
A Phase II Study of Locally Advanced Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT00010088 2009-02-09
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00149578 2007-05-17
A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT00323583 2007-05-08
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
Seattle Cancer Treatment and Wellness Center
Phase 2 Unknown